<--- Back to Details
First PageDocument Content
European Parliament / European Union / Venice Commission / European Commission / Constitution of Hungary / Council of Europe / EU patent / Prague Declaration on European Conscience and Communism / Language law of Slovakia / Europe / Politics / Viktor Orbán
European Parliament
European Union
Venice Commission
European Commission
Constitution of Hungary
Council of Europe
EU patent
Prague Declaration on European Conscience and Communism
Language law of Slovakia
Europe
Politics
Viktor Orbán

Add to Reading List

Source URL: europa.eu

Download Document from Source Website

File Size: 115,00 KB

Share Document on Facebook

Similar Documents

PRESS RELEASE  March 19, 2008 European Business Leaders Call for a Simplified Patent Process to Drive Innovation Europe’

PRESS RELEASE March 19, 2008 European Business Leaders Call for a Simplified Patent Process to Drive Innovation Europe’

DocID: 1szK3 - View Document

PRES SEMI TTE ILUN G IDnow wird Europameister: Erstes Patent für Video-Identifizierung EU vereinheitlicht digitalen Vertragsabschluss zum 1. Juli 2016, IDnow hat die passende Lösung München, 1. Juni 2016 – Europawei

PRES SEMI TTE ILUN G IDnow wird Europameister: Erstes Patent für Video-Identifizierung EU vereinheitlicht digitalen Vertragsabschluss zum 1. Juli 2016, IDnow hat die passende Lösung München, 1. Juni 2016 – Europawei

DocID: 1s15r - View Document

für käse  Wir haben das Patent...  ... Sie haben

für käse Wir haben das Patent... ... Sie haben

DocID: 1ruux - View Document

SINGLE RESOLUTION BOARD VACANCY NOTICE SENIOR LEGAL EXPERT IN BANKING REGULATION AND RESOLUTION (SRB/ADType of contract

SINGLE RESOLUTION BOARD VACANCY NOTICE SENIOR LEGAL EXPERT IN BANKING REGULATION AND RESOLUTION (SRB/ADType of contract

DocID: 1rrDz - View Document

27 JANUARY 2016 BIOSIMILARS DEVELOPMENT - FROM PRE-CLINIC TO MARKET Several biological products, altogether worth over US$60 billion annual sales, are encountering patent expiry byThis opens up the opportunity for

27 JANUARY 2016 BIOSIMILARS DEVELOPMENT - FROM PRE-CLINIC TO MARKET Several biological products, altogether worth over US$60 billion annual sales, are encountering patent expiry byThis opens up the opportunity for

DocID: 1rnQJ - View Document